Strategic Intelligence

Market, competitive, patient, HCP, KOL, brand, and asset intelligence embedded directly into decision workflows.

Strategic intelligence should not wait for disconnected research cycles. Improzo turns fragmented market and external signals into decision-ready intelligence.

The Strategic Intelligence Gap

Strategy teams in pharma carry some of the most consequential decisions in the organization — portfolio direction, competitive positioning, patient targeting, and asset prioritization. The challenge is not analytical capability. It is that the intelligence needed to act arrives too slowly, too fragmented, and too disconnected to drive decisions in real time.

  • Every strategic decision deserves current intelligence — not findings from a research cycle that closed six weeks ago while the market kept moving.
  • Every competitor move deserves early visibility — teams should shape their response before the market shift becomes a leadership conversation.
  • Every patient journey, HCP segment, and asset opportunity deserves a connected view — not three separate workstreams that never talk to each other.
  • Every portfolio decision deserves continuously updated context — not a static deliverable that is outdated before it reaches the decision maker.
The Strategic Intelligence Gap

Intelligence Across Strategy, Market, and Portfolio Decisions

Strategic decisions are still shaped by fragmented research cycles, competitive updates, patient journey work, HCP segmentation, and portfolio analysis. Strategic Intelligence creates a more continuous way to interpret market movement and turn it into decision-ready narratives.

Market Research

Turn interviews, reports, transcripts, and research outputs into structured findings and strategic narratives.

Competitive Intelligence

Track competitor activity across messaging, science, launches, market movement, and external sources.

Patient Journey

Map barriers, drop-offs, access issues, experience signals, and segment-level differences.

HCP & KOL Intelligence

Organize HCP segments, KOL influence, activity patterns, and engagement context.

Asset Scouting

Support BD, licensing, and portfolio teams with faster views of asset, market, and competitive fit.

From Market Signal to Strategic Decision

From Market Signal to Strategic Decision

Strategic Intelligence uses advanced AI to continuously monitor, structure, and surface market, competitive, and portfolio signals — so strategy teams spend less time compiling intelligence and more time acting on it.

  • Always-On Market & Competitive Intelligence

    Monitor competitor activity, market movement, publication shifts, and external signals continuously. Replace reactive intelligence gathering with a live view that updates as the market moves.
  • Patient & HCP Intelligence

    Structure patient journey barriers, HCP segments, and KOL influence into connected intelligence that brand, access, and field teams can act on together — not in separate workstreams.
  • Portfolio & Asset Decisioning

    Support BD, licensing, and portfolio teams with faster views of asset fit, market context, and competitive landscape so decisions move at the speed opportunities require.

See Strategic Intelligence accelerators live

Bring market, competitive, patient, HCP, KOL, brand, and asset intelligence into always-on decision workflows.

Market Research AI

Converts research inputs, interviews, reports, and documents into decision-ready intelligence.

  • Summarize research outputs
  • Identify market themes
  • Generate decision narratives
Market Research AI

Competitive Intelligence

Monitors competitor movement across messaging, market activity, science, and external signals.

  • Track competitor updates
  • Summarize positioning shifts
  • Identify market risks
Competitive Intelligence

Patient Journey AI

Structures patient journey barriers, drop-offs, access issues, and experience signals.

  • Map journey friction
  • Identify access barriers
  • Support brand and access strategy
Patient Journey AI

HCP & KOL Intelligence

Builds structured intelligence around HCP segments, KOL activity, and influence patterns.

  • Organize HCP segments
  • Map KOL influence
  • Track engagement context
  • Support targeting decisions
HCP & KOL Intelligence

Asset Scouting

Supports BD, licensing, and portfolio teams with faster asset and market intelligence.

  • Screen asset opportunities
  • Summarize market context
  • Compare competitive fit
  • Support diligence workflows
Asset Scouting

Market Research AI

Converts research inputs, interviews, reports, and documents into decision-ready intelligence.

  • Summarize research outputs
  • Identify market themes
  • Generate decision narratives

Competitive Intelligence

Monitors competitor movement across messaging, market activity, science, and external signals.

  • Track competitor updates
  • Summarize positioning shifts
  • Identify market risks

Patient Journey AI

Structures patient journey barriers, drop-offs, access issues, and experience signals.

  • Map journey friction
  • Identify access barriers
  • Support brand and access strategy

HCP & KOL Intelligence

Builds structured intelligence around HCP segments, KOL activity, and influence patterns.

  • Organize HCP segments
  • Map KOL influence
  • Track engagement context
  • Support targeting decisions

Asset Scouting

Supports BD, licensing, and portfolio teams with faster asset and market intelligence.

  • Screen asset opportunities
  • Summarize market context
  • Compare competitive fit
  • Support diligence workflows

Insights & Thinking That Shape Better Decisions

How life sciences organizations are moving beyond analytics into agentic AI systems that actively execute, optimize, and adapt in real time.

Our Experts

Abhishek Trigunait

Abhishek Trigunait

Cofounder and Chief Technology Officer

Inderpreet Kambo

Inderpreet Kambo

Cofounder and Chief Executive Officer